One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients

Bibliographic Details
Main Authors:	Vitaliana De Sanctis, Daniela Musio, Francesca Felice, Francesco Marampon, Maurizio Valeriani, Paolo Bonome, Dimitri Anzellini, Giuseppe Facondo, Gianluca Vullo, Maria Massaro, Mario Di Staso, Pierluigi Bonfili, Agnieszka Chalaszczyk, Giovanni Gravina, Vincenzo Tombolini, Mattia Osti
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-04-01
Series:	Journal of Contemporary Brachytherapy
Subjects:	endometrial cancer brachytherapy vaginal vault toxicity survival local recurrence
Online Access:	https://www.termedia.pl/One-week-vaginal-brachytherapy-schedule-as-exclusive-adjuvant-post-operative-treatment-in-intermediate-and-high-intermediate-risk-endometrial-cancer-patients,54,40410,1,1.html

Similar Items

Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
by: Maurizio Valeriani, et al.
Published: (2022-08-01)

Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
by: Giuseppe Facondo, et al.
Published: (2022-08-01)

Clinical outcomes of patients treated with template-based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysis
by: Gargee Mulye, et al.
Published: (2022-12-01)

Modified Houdek vault applicator for high-dose-rate brachytherapy: a technical report and case series
by: Revathy Krishnamurthy, et al.
Published: (2021-12-01)

The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review
by: Valentina Lancellotta, et al.
Published: (2020-02-01)

Dosimetric comparison of interstitial brachytherapy with multi-channel vaginal cylinder plans in patients with vaginal tumors
by: Lucas C. Mendez, et al.
Published: (2017-05-01)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
by: Hiroaki Kunogi, et al.
Published: (2020-12-01)

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
by: Keisei Okamoto, et al.
Published: (2020-02-01)

Comprehensive brachytherapy : physical and clinical aspects /
by: Venselaar, Jack
Published: (2013)

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center
by: Bengt Johansson, et al.
Published: (2021-05-01)

Comparison of dosimetric analysis of organs at risk and target volumes for ovoids and cylinders in endometrial carcinoma
by: Yashaswini BR, et al.
Published: (2023-12-01)

Can brachytherapy be properly considered in the clinical practice? Trilogy project: The vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group
by: Luca Tagliaferri, et al.
Published: (2020-02-01)

Evolution of brachytherapy applicators for the treatment of cervical cancer
by: Ankur Mourya, et al.
Published: (2021-01-01)

Brachytherapy dose changes: comparing in-room and out-room image-guided brachytherapy. A randomized study
by: Pooriwat Muangwong, et al.
Published: (2022-08-01)

The physics of modern brachytherapy for oncology /
by: 416436 Baltas, Dimos, et al.
Published: (2007)

Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey
by: Luca Tagliaferri, et al.
Published: (2019-02-01)

Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma
by: Rutvij A. Khanolkar, et al.
Published: (2021-09-01)

Brachytherapy practice during the COVID-19 pandemic: a review on the practice changes
by: Mansi Barthwal, et al.
Published: (2020-07-01)

Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer
by: Hideyasu Tsumura, et al.
Published: (2022-04-01)

Is adaptive treatment planning for single-channel vaginal brachytherapy necessary?
by: Jan-Erik Palmgren, et al.
Published: (2021-12-01)

High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
by: Delphine Marotte, et al.
Published: (2022-07-01)

Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival
by: Sophie Robin, et al.
Published: (2021-08-01)

Ruthenium brachytherapy for iris melanoma
by: Emilia Zwolińska, et al.
Published: (2023-10-01)

The role of radiation therapy technologist in interventional radiotherapy (brachytherapy) in Italy: Italian Association of Radiotherapy and Clinical Oncology (AIRO) and Italian Association of Radiation Therapy and Medical Physics Technologists (AITRO) joint project
by: Patrizia Cornacchione, et al.
Published: (2021-12-01)

Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy
by: Umesh Mahantshetty, et al.
Published: (2019-08-01)

Clinical advantage and outcomes of computed tomography‐based transvaginal hybrid brachytherapy performed only by sedation without general or saddle block anesthesia
by: Noriyuki Okonogi, et al.
Published: (2022-11-01)

Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience
by: Justin Barnes, et al.
Published: (2019-10-01)

Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer
by: Manabu Kato, et al.
Published: (2023-11-01)

Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
by: Yoshiaki Ota, et al.
Published: (2020-06-01)

Feasibility and clinical implementation of MRI-guided surface brachytherapy
by: Michael J. Lavelle, et al.
Published: (2024-02-01)

Estimating the accumulative dose uncertainty for intracavitary and interstitial brachytherapy
by: Binbing Wang, et al.
Published: (2021-10-01)

Current Status and Future Directions of Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer
by: Nicholas Eustace, et al.
Published: (2024-03-01)

Winning jumps and pole vault /
by: Jacoby, Ed
Published: (2009)

Feasibility of outpatient hybrid brachytherapy for cervical cancer with minimal sedation: Results from a single-institutional protocol
by: Subhakar Mutyala, et al.
Published: (2023-02-01)

Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers
by: Giuseppe Facondo, et al.
Published: (2023-01-01)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
by: Maria Massaro, et al.
Published: (2021-09-01)

Current status and future readiness of Indian radiation oncologists to embrace prostate high-dose-rate brachytherapy: An Indian Brachytherapy Society survey
by: Susovan Banerjee, et al.
Published: (2023-12-01)

Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy
by: Keiko Nemoto Murofushi, et al.
Published: (2021-02-01)

Comparison of two high dose rate brachytherapy regimes
by: Gaurav Jaswal, et al.
Published: (2023-01-01)

Iodine-125 brachytherapy for brain tumours - a review
by: Schwarz Silke B, et al.
Published: (2012-03-01)